Stocksigma LogoStocksigma Logo

RPG Life Sciences' API Carve-Out, PE Partnership, and Twin Acquisitions

RPG Life Sciences subsidiarized its API business into RPG Active Pharma (RPGAP). PE firm InvAscent is acquiring a 40% stake in RPGAP for ~INR 243.33 Cr

RPG Life Sciences' API Carve-Out, PE Partnership, and Twin Acquisitions

RPG Life Sciences Ltd 路 Investor Presentation 路 03 Sept 2026, 4:04 am

RPG Life Sciences' API Carve-Out, PE Partnership, and Twin Acquisitions RPG Life Sciences subsidiarized its API business into RPG Active Pharma (RPGAP). PE firm InvAscent is acquiring a 40% stake in RPGAP for ~INR 243.33 Cr. Concurrently, RPGAP announced two acquisitions: 100% of Actis Generics for ~INR 80 Cr and Raghava Life Sciences via a ~INR 135 Cr slump sale. These strategic transactions quadruple RPGAP's installed capacity across Vizag and Hyderabad, add ~INR 200 Cr in revenue potential, and strengthen its high-margin niche API portfolio while maintaining a zero-debt balance sheet.

Original exchange filing (PDF)

More announcements from RPG Life Sciences Ltd

All RPG Life Sciences Ltd announcements